Loading organizations...
Loading organizations...
Gene engineering mAb company developing treatments for Ebola and cancer.
Mabworks has raised $39.0M across 1 funding round.
Mabworks has raised $39.0M in total across 1 funding round.
Mabworks has raised $39.0M in total across 1 funding round.
Mabworks's investors include GTJA Investment Group.
Mabworks has raised $39.0M across 1 funding round. Most recently, it raised $39.0M Series B in January 2017.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jan 25, 2017 | $39.0M Series B | GTJA Investment Group |